- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06093386
Promoting Intensive Transitions for Children and Youth With Medical Complexity From Pediatric to Adult Care (PITCare)
Medical advances have allowed many more children and youth with medical complexity (CMC) to survive well into adulthood. However, this has not been matched with increases in knowledge of complex conditions or the availability of supports as they transition into the adult care system. The goal of this randomized control trial is to compare intensive transition support from a transition team, led by an advance practice nurse, during transition to adult care for 2 years, with usual care in CMC. Participants assigned to the intervention group will be offered support in care planning, receiving funding, and connecting with a primary care provider and adult subspecialists.
The main questions it aims to answer are:
- Does intensive transition support improve the patient's continuity of care over 2 years compared with usual care?
- Will there be differences between intervention and control groups with respect to other outcomes related to the youth/family's satisfaction with care, care coordination, self-care, health service utilization, cost-effectiveness, and quality of life?
- What are the experiences of youth, parents, the transition team, and other clinicians involved in the intensive transition support process?
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sara Santos
- Phone Number: 309085 416-813-7654
- Email: sara.santos@sickkids.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada
- Recruiting
- The Hospital for Sick Children
-
Contact:
- Sara Santos
- Email: sara.santos@sickkids.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patients 17 years 6 months- 17 years 9 months old (inclusive) who meet Ontario's CMC definition:
- technology dependence and/or users of high-intensity care,
- fragility (severe and/or life-threatening condition,
- chronicity (expected to last at least 6 months),
- complexity (involvement of ≥5 healthcare practitioners/teams and healthcare services in ≥ 3 locations such as home, school, hospital, etc.).
Exclusion Criteria:
- are expected to die within 2 years of recruitment (e.g., those receiving active end-of-life care)
- do not have a stable primary caregiver (e.g., those who reside in residential or long-term care facilities, and those in foster care as the intervention is focused on a patient-caregiver dyad)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
|
Participants assigned to the intervention arm will transfer their transition support leadership to a transition team composed of a transition navigator (an advance practice nurse), a nurse navigator (a registered nurse) and a social worker over 2 years to support them through the multiple phases of CMC transitions including guidance, monitoring, planning, care transfer and transfer completion.
CMC and their caregivers will be offered support in care planning, receiving funding, and connecting with a primary care provider and adult subspecialists.
|
|
No Intervention: Control/ Usual Care
Standard of care in the control group will involve the utilization of existing tools within clinical programs which may include preparation for transitions, but there will be no systematic follow-up by a paediatric provider beyond age 18. Care will be transferred to adult providers (primary care and specialists) via a transition guide that will be offered to participants and their referring providers.
This is the current model of care for virtually all CMC in Ontario.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Transfer Completion
Time Frame: 6 to 30 months
|
Successful transfer of primary and subspecialty care to continuous primary care and a prioritized subspecialty in adult care will be measured using a relational continuity of care measure - the Bice Boxerman Index (modified for the study population).
|
6 to 30 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Transfer Completion
Time Frame: Baseline to 24 months
|
Successful transfer of primary and subspecialty care to continuous primary care and a prioritized subspecialty in adult care will be measured using a relational continuity of care measure - the Bice Boxerman Index (modified for the study population).
|
Baseline to 24 months
|
|
Transfer Completion
Time Frame: 6 to 30 months
|
Successful transfer of primary care to continuous adult primary care will be measured using a relational continuity of care measure - the Bice Boxerman Index.
|
6 to 30 months
|
|
Transfer Completion
Time Frame: 6 to 30 months
|
Successful transfer of subspecialty care to continuous care from a prioritized subspeciality provider in adult care will be measured using a relational continuity of care measure - the Bice Boxerman Index.
|
6 to 30 months
|
|
Transfer Completion
Time Frame: Baseline to 24 months
|
Successful transfer of subspecialty care to continuous care from all subspecialty providers in adult care will be measured using a relational continuity of care measure - the Bice Boxerman Index.
|
Baseline to 24 months
|
|
Transfer Completion
Time Frame: Baseline to 24 months
|
The proportion of patients who receive a Bice Boxerman Index score of 0 (< 2 visits to both a subspecialty and primary care provider) will be assessed.
|
Baseline to 24 months
|
|
Transfer Completion
Time Frame: Baseline to 24 months
|
The proportion of visits to all primary care providers that are made to the usual care provider will be assessed among individuals who had ≥ 3 primary care visits (UPC Index).
|
Baseline to 24 months
|
|
Early Identification and Transition Readiness- Satisfaction with Transitional Healthcare
Time Frame: Baseline, 12 months and 24 months
|
The change in caregiver satisfaction with transitional health care services will be measured using the Larsen Client Satisfaction Questionnaire (CSQ) (8-item).
The change in patient satisfaction will also be measured with the CSQ where able.
Comparisons will be made between intervention and control groups.
|
Baseline, 12 months and 24 months
|
|
Early Identification and Transition Readiness- Self-Care
Time Frame: Baseline, 12 months and 24 months
|
The change in the caregiver's family empowerment status will be measured with the Family Empowerment Scale (24-item).
Scoring will be accomplished by summing responses from items within the family (12 items) and service system (12 items) to generate sub-scores.
Comparisons will be made between intervention and control groups.
|
Baseline, 12 months and 24 months
|
|
Early Identification and Transition Readiness- Self-Care
Time Frame: Baseline
|
The change in the patient's knowledge and confidence in managing their health will be measured (if able) using the Patient Activation Measure (10-item).
Comparisons will be made between intervention and control groups.
|
Baseline
|
|
Information Sharing and Support, Transition Plan and Coordinated Transition
Time Frame: Baseline, 12 months and 24 months
|
The change in utility of care planning tools, written transition plan assessment, coordination of care among providers and families and, coordination of care between providers and families will be assessed with the Family Experiences with Coordination of Care (FECC) survey, completed by the caregiver.
Comparisons will be made between intervention and control groups.
|
Baseline, 12 months and 24 months
|
|
Introduction to Adult Services
Time Frame: 24 months
|
The number of patients who have received (presence or absence) adult-oriented funding and services will be assessed via report by the caregiver or, if able, the youth (e.g., receipt of Ontario Disability Support Program ODSP funding).
Comparisons will be made between intervention and control groups.
|
24 months
|
|
Use of Services
Time Frame: Baseline to 24 months
|
Low acuity emergency department visits, emergency department use, hospitalization, technological complications, and immunization will be captured using encoded health administrative data housed at ICES to determine the patient's health care and preventative care use.
Comparisons will be made between intervention and control groups.
|
Baseline to 24 months
|
|
Use of Services- Incremental Cost-Utility Ratio (ICUR)
Time Frame: Baseline to 24 months
|
A probabilistic cost-utility analysis will be conducted using patient-level data, to determine the incremental cost per quality-adjusted life-year gained (QALY) of intensive transition support compared to usual care, from a health system perspective.
QALY gains for both patient and caregiver will be included.
All direct health care costs and health service utilization will be ascertained from study data linked to administrative datasets at ICES.
Utility, determined by mapping patient and caregiver responses to the EQ-5D-5L, will be used to generate QALY gains (or losses) over the time horizon.
|
Baseline to 24 months
|
|
Health-Related Quality of Life
Time Frame: Baseline, 12 months and 24 months
|
The change in overall health-related quality of life of both the patient and their caregiver will be measured using the EQ-5D-5L.
The digit for each of the scale's five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) can be combined into a 5-digit number that describes the patient's health state and is commonly used to estimate health utilities.
The descriptive system is complemented by a visual analogue scale where patients record their self-rated health.
Comparisons will be made between intervention and control groups.
|
Baseline, 12 months and 24 months
|
|
Health-Related Quality of Life-Caregiver Fatigue
Time Frame: Baseline, 12 months and 24 months
|
The change in caregiver fatigue will be measured using the PROMIS Fatigue Scale (8-item).
The Fatigue scale is divided into the experience of fatigue (frequency, duration, and intensity) and the impact of fatigue on physical, mental, and social activities.
Each question has five response options ranging in value from one to five.
Comparisons will be made between intervention and control groups.
|
Baseline, 12 months and 24 months
|
|
Health-Related Quality of Life- Family Distress
Time Frame: Baseline, 12 months and 24 months
|
The change in family distress will be assessed using the Brief Family Distress Scale (1-item) completed by the caregiver.
The 10-point Likert scale is used to measure crisis level, which is assigned by groupings of the scale continuum, with a level between 1-3 indicating no impairment, 4-5, moderate impairment, and 6-10, marked impairment.
Comparisons will be made between intervention and control groups.
|
Baseline, 12 months and 24 months
|
|
Experiences in The Process
Time Frame: 12 to 24 months
|
Semi-structured qualitative interviews will be conducted with a subset of intervention participants, health care providers, including both pre-transition and post-transition clinicians, and the transition team to gauge their experience with the transition support process.
|
12 to 24 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implementation Progress Outcomes- Care Planning
Time Frame: Baseline to 24 months
|
The implementation process will be assessed by determining the fidelity of the intervention using percentages of completion for each of the four main intervention components.
The percentage of completed care planning documentation will be captured by the transition team for those participants assigned to the intervention group.
|
Baseline to 24 months
|
|
Implementation Progress Outcomes- Integration with Primary Care Providers
Time Frame: Baseline to 24 months
|
The implementation process will be assessed by determining the fidelity of the intervention using percentages of completion for each of the four main intervention components.
The percentage of primary care visits scheduled and attended by the transition team will be captured by the transition team for those participants assigned to the intervention group.
|
Baseline to 24 months
|
|
Implementation Progress Outcomes- Adult Subspecialty Facilitation
Time Frame: Baseline to 24 months
|
The implementation process will be assessed by determining the fidelity of the intervention using percentages of completion for each of the four main intervention components.
The percentage of joint adult subspecialty visits and visits scheduled and attended by the transition team will be captured by the transition team for those participants assigned to the intervention group.
|
Baseline to 24 months
|
|
Implementation Progress Outcomes- Facilitation of Funding
Time Frame: Baseline to 24 months
|
The implementation process will be assessed by determining the fidelity of the intervention using percentages of completion for each of the four main intervention components.
The percentage of eligible funding applications completed and received will be captured by the transition team for those participants assigned to the intervention group.
|
Baseline to 24 months
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1000080621
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Children and Youth With Medical Complexity
-
University of UtahNational Institute of Nursing Research (NINR)RecruitingChildren With Medical ComplexityUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...University Medical Center Groningen; Erasmus Medical Center; ZonMw: The Netherlands... and other collaboratorsRecruitingChildren with Medical ComplexityNetherlands
-
Wake Forest University Health SciencesPatient-Centered Outcomes Research InstituteRecruitingChildren With Medical ComplexityUnited States
-
Wake Forest University Health SciencesCompletedChildren With Medical ComplexityUnited States
-
NYU Langone HealthEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingChildren With Medical Complexity (CMC)United States
-
The Hospital for Sick ChildrenChildren's Hospital of Eastern Ontario; Montreal Children's Hospital of the...CompletedMedical Education | Children With Medical Complexity | Complex Care | Pediatric ResidentsCanada
-
Children's Mercy Hospital Kansas CityWithdrawnPediatrics | Nursing | Children With Medical Complexity (CMC) | Medically ComplexUnited States
-
The Hospital for Sick ChildrenHamilton Health Sciences Corporation; London Health Sciences Centre; Children...Completed
-
University of ChicagoNational Institute on Minority Health and Health Disparities (NIMHD)CompletedEmpowerment | Children With Medical Complexity | Invasive Mechanical Ventilation | Home NursingUnited States
-
University of UtahHRSA/Maternal and Child Health BureauCompletedChildren With Medical ComplexityUnited States
Clinical Trials on Intensive Transition Support
-
University of HelsinkiRoyal Children's Hospital; Murdoch Childrens Research Institute; University of... and other collaboratorsActive, not recruitingLiver Diseases | Kidney Diseases | Diabetes | Rheumatic Diseases | Inflammatory Bowel Diseases | Neurologic Disorder | Congenital Heart Disease | TransitionAustralia, Finland
-
Karolinska InstitutetForteCompletedStroke | Transient Ischemic AttackSweden
-
McGill UniversityCompletedAutism Spectrum DisorderCanada
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknown
-
Günther FinkActive, not recruitingMalnourished Children | Stunting of GrowthZambia
-
Yale UniversityNational Institute on Aging (NIA)Not yet recruitingDementia | Emergency Department | Caregiver | Mobile Health Technology (mHealth)United States
-
University College, LondonCompleted
-
The Miriam HospitalBrown University; Tufts Medical CenterCompleted
-
University of MinnesotaUniversity of Southern California; Wake Forest UniversityCompleted
-
University of OuluCompleted